Company intelligence / Profile preview
Osteal Therapeutics
San Clemente, California, United Statesostealtx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Osteal Therapeutics has developed VT-X7 KIT, a combination drug/device product delivering vancomycin and tobramycin directly into infected joints. The company recently announced positive results from two prospective randomized APEX clinical trials in PJI patients, showing improved outcomes with rapid exchange arthroplasty compared to standard care. VT-X7 has received FDA orphan drug, fast track, qualified infectious disease product, and breakthrough therapy designations. The company plans an NDA submission and commercial launch preparation in the near term[3][6][8].
- Therapeutic areas
- Infectious Diseases
- Modalities
- Combination drug/device therapy (local delivery of antimicrobials)Antibiotics (vancomycin hydrochloride and tobramycin sulfate)[6]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Osteal Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Osteal Therapeutics.